68Ga-NODAGA-ZIGF-1R:4:40

N/A

Report date: 2025/10/20 14:27:14

NME

Base Information

Drug Name68Ga-NODAGA-ZIGF-1R:4:40

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-Insulin-like growth factor I receptor

TargetsInsulin-like growth factor I receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesHarbin Medical University

China Registration ClassN/A

Develop Information

Active CompaniesHarbin Medical University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A